I am writing this blog after reading a recent article about the relationship between viral infections and neurodegenerative diseases. I believe this article references a landmark study in terms of discussing neurodegenerative conditions as it analyzes the medical records of over 500,000 people, supporting the idea that there is a link between viral infection and an increased risk of developing diseases like Alzheimer’s, Parkinson’s, and ALS.
By analyzing the medical records of over a half-million people, the study provides robust statistical evidence to support this research. The large dataset makes the findings more definitive.
Specifically, the study found that people who had viral encephalitis were 31 times more likely to develop Alzheimer’s later.
Other viral infections like pneumonia, intestinal infections, meningitis, and shingles were also associated with heightened susceptibility to neurodegenerative diseases. The effects of the viral infections persisted for up to 15 years in some cases.
One important fact is that over 80% of the implicated viruses could cross the blood-brain barrier. This suggests the viruses directly infect and inflame the nervous system. The researchers note that vaccines exist for viruses like flu, shingles, and pneumonia. They hypothesize that vaccination could mitigate the risk of developing neurodegenerative disease later in life.
This study adds evidence to the emerging theory that viral infections and inflammation may contribute significantly to brain diseases previously thought to be driven chiefly by genetic and molecular factors. This could shift the research paradigm and the implications could dramatically improve brain health over the long term if viral triggers can be reduced or eliminated through various methods. One method in particular that comes to mind is EBO2.
This is where EBO2 may have a significant overall effect. Recently, I posted a blog on how many viruses stay in our bodies only to become reactivated under the right circumstances. In this case, I was referring more to the viruses we picked up as children, such as CMV, etc.
This current article now expands the field to include viruses we get infected with as adults. I would place COVID in the category. We can prevent these viruses from causing long-term neurodegenerative damage by eliminating them. Remember, EBO2 destroys viruses in two ways.
First, it can destroy the virus’s lipid membrane and expose its DNA and RNA to various damages, rendering it impotent. Secondly, the exposure of the UVA and especially the UVC wavelength from the Hemealumen will further damage the viral DNA and RNA.
By dramatically reducing the viral load, the body can handle the viral insults better and hopefully prevent neurodegenerative conditions from arising. Thus, the EBO2 technique will directly target and reduce the viral load and inflammation that this study links to a heightened risk of neurodegenerative diseases. By cleaning the blood of triggers that can cross the blood-brain barrier, it may be possible to lower the chances of developing Alzheimer’s, Parkinson’s, and other brain disorders.
This is why I now recommend an EBO2 treatment every six months to keep the viral load down. If one has a bad viral infection, it might be a good idea to follow up with an additional EBO2.
The final question I will pose: will we see even more of an epidemic of neurodegenerative conditions due to all the COVID-19 infections? Only time will tell. But hopefully, EBO2 and other techniques will stem the tide.
If you’d like to learn more about EBO2 or to set up your EB02 treatment, click here
You may also find this article by Dr. Purita helpful:
How EBO2 May Protect Against Glyphosate-Cause Illness.
*These statements have not been evaluated by the FDA and do not constitute medical advice.
